Form 10 Explorer
10-Q
Quarterly Report
BIOMERICA, INC.

BMRA

NASDAQ

CIK: 73290

File #: 001-37863

Period End: Nov 30, 2023

Fiscal Year: 2024

View on EDGAR
Balance Sheet
35 line items · 2 periods
XBRL
ItemNov 30, 2023May 31, 2023
Assets
Current Assets:
Cash and Cash Equivalents
7,134,0009,719,000
Accounts Receivable
1,067,000722,000
Inventory
1,841,0002,056,000
Other Non-Operating Current Assets
223,000300,000
Total current assets
10,265,00012,797,000
Property, Plant and Equipment
210,000213,000
MEXICO
16,00017,000
Operating Lease Right-of-Use Asset
891,0001,035,000
Cash and Cash Equivalents
165,000165,000
Polish Distributor
165,000—
Intangible Assets
204,000165,000
Other Non-Operating Non-Current Assets
96,00079,000
Total Assets
11,831,00014,454,000
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts Payable
783,000892,000
Other Current Liabilities
668,000696,000
Other Current Liabilities
60,00060,000
Operating Lease Liability, Current
311,000297,000
Total current liabilities
1,822,0001,945,000
Operating Lease Liability, Non-Current
626,000785,000
Total Liabilities
2,448,0002,730,000
Shareholders’ Equity:
Total Stockholders' Equity
1,346,0001,346,000
Total Stockholders' Equity
52,997,00052,705,000
Total Stockholders' Equity
(104,000)(110,000)
Total Stockholders' Equity
(44,856,000)(42,217,000)
Total Shareholders’ Equity
9,383,00011,724,000
Common Stock
1,346,0001,346,000
Additional Paid-in Capital
52,997,00052,705,000
AOCI Attributable to Parent
(104,000)(110,000)
Retained Earnings
(44,856,000)(42,217,000)
Total Liabilities and Shareholders’ Equity
11,831,00014,454,000
BIOMERICA, INC. (BMRA) — 10-Q Filing | Form 10 Explorer